A Safety and Efficacy Study of XH001 (Neoantigen Cancer Vaccine) Combined With Sintilimab Injection in Advanced Solid Tumors
Latest Information Update: 14 Jul 2023
At a glance
- Drugs Sintilimab (Primary)
- Indications Solid tumours
- Focus Adverse reactions
Most Recent Events
- 14 Jul 2023 New trial record